查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
中國血液疾病藥物市場
市場調查報告書
商品編碼
1673512

中國血液疾病藥物市場

Blood Disease Drugs Markets in China
出版日期: | 出版商: Asia Market Information & Development Co. | 英文 290 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

過去十年，中國對血液疾病藥物的需求快速成長。預計未來十年產量和需求都將持續成長。中國經濟持續快速成長，工業產量、進出口、消費支出和資本投資連續二十多年成長。

本報告調查了中國的血液疾病治療藥物市場，涵蓋了中國的經濟趨勢、投資環境、市場發展、供需、產業產能、產業結構、行銷管道以及主要行業參與者。介紹中國主要生產商的概況，包括歷史資料（2014年、2019年、2024年）以及2029年和2034年的長期預測。

目錄

第1章 簡介

第2章 商業環境

  • 經濟展望
  • 主要經濟指標
  • 工業生產
  • 人口和勞動力
  • 外國投資
  • 貿易
  • 金融和稅務法規
  • 銀行體系與監管
  • 外匯
  • 稅金、關稅和海關費用

第3章 血液學藥物產業評估

  • 血液學藥物產業結構
  • 市場規模
  • 市場成長動力
  • 血液疾病藥物銷售量
  • 主要生產設施所在地及銷售量
  • 主要生產商的市場佔有率
  • 勞動成本
  • 潛在參與者
  • 主要經銷商
  • 重大外國投資
  • 技術開發

第4章 血液疾病藥物的生產與需求

  • 概述
  • 各地區對血液疾病藥物的需求
  • 血液疾病藥物銷售量
  • 貧血治療藥物
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • 治療嗜中性白血球減少症和粒細胞缺乏症的藥物
  • 維生素 B4
  • Batilol
  • 肌苷
  • 脫氧核糖核苷酸
  • 腎上腺皮質激素
  • 粒細胞集落刺激因子（G-CSF）
  • 白血病藥物銷售量
  • 干擾素
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • 其他血液疾病藥物銷售量
  • 血液疾病治療藥品進口
  • 貧血治療藥物
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • 進口治療嗜中性白血球減少症和粒細胞缺乏症的藥品
  • 維生素 B4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • 粒細胞集落刺激因子（G-CSF）
  • 進口白血病治療藥物
  • 干擾素
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • 進口其他血液疾病藥物
  • 價格趨勢

第5章 血液學藥物市場展望

  • 血液學藥物市場前景概述
  • 政府監管
  • 健康保險產業概覽
  • 消費者支出趨勢
  • 醫療保健產業趨勢
  • 醫院和病床

第6章 行銷策略

  • 中國市場進入概述
  • 中國的分銷體系
  • 橡膠加工化學品的通路
  • 交通運輸及貨運基礎設施
  • 通訊
  • 進入中國市場
  • 許可
  • 特許經營
  • 電子商務
  • 貿易公司和當地代理商
  • 在中國的代表處和子公司
  • 100%外商獨資公司

第7章 血液學藥物製造商名錄

第1章 簡介

  • 經濟前景摘要

第2章 商業環境

  • 主要經濟指標
  • 工業生產
  • 人口和勞動趨勢
  • 外國投資與貸款
  • 貿易

第3章 血液學藥物產業評估

第4章 血液疾病藥物的生產與需求

第5章 血液學藥物市場展望

Product Code: 805

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2014, 2019 and 2024) and long-term forecasts through 2029 and 2034 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Blood Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Blood Disease Drugs by Region
  • Blood Disease Drugs Sales Volume
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Sales Volume
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Imports
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs Imports
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Imports
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Imports
  • Pricing Trends

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Blood Disease Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY

  • Blood Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations
  • ULIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Location
  • Major Blood Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Major Producer and Their Market Share
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Anemia Treatment Drugs Major Producer and Their Market Share
  • Mecobalamin Major Producer and Their Market Share
  • Cobamamide Major Producer and Their Market Share
  • Ferrous Succinate Major Producer and Their Market Share
  • Leucogen Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Major Producer and Their Market Share
  • Batilol Major Producer and Their Market Share
  • Inosine Major Producer and Their Market Share
  • Deoxyribonucleotide Major Producer and Their Market Share
  • Adrenocortical Hormone Major Producer and Their Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
  • Leukemia Treatment Drugs Major Producer and Their Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Major Producers and Their Market Share
  • Imatinib Mesylate Major Producer and Their Market Share
  • Rituximab Major Producer and Their Market Share
  • Pirarubicin Major Producer and Their Market Share
  • Hydroxycampothecin Major Producer and Their Market Share
  • Blood Disease Drugs Import
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • Leukemia Treatment Drugs Import Volume by Drugs Classification

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

ULIST OF CHARTS

I. NTRODUCTION

  • Blood Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Blood Disease Drugs Sales Volume
  • Worldwide Blood Disease Drugs Demand by region
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Mecobalamin Sales Volume and Market Share
  • Cobamamide Sales Volume and Market Share
  • Ferrous Succinate Sales Volume and Market Share
  • Leucogen Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Sales Volume and Market Share
  • Batilol Sales Volume and Market Share
  • Inosine Sales Volume and Market Share
  • Deoxyribonucleotide Sales Volume and Market Share
  • Adrenocortical Hormone Sales Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Sales Volume and Market Share
  • Imatinib Mesylate Sales Volume and Market Share
  • Rituximab Sales Volume and Market Share
  • Pirarubicin Sales Volume and Market Share
  • Hydroxycampothecin Sales Volume and Market Share
  • Other Blood Disease Drugs Sales volume and Market Share
  • Blood Disease Drugs Import Volume
  • Anemia Import Volume and Market Share
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Mecobalamin Import Volume and Market Share
  • Cobamamide Import Volume and Market Share
  • Ferrous Succinate Import Volume and Market Share
  • Leucogen Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • VitamineB4 Import Volume and Market Share
  • Batilol Import Volume and Market Share
  • Inosine Import Volume and Market Share
  • Deoxyribonucleotide Import Volume and Market Share
  • Adrenocortical Hormone Import Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume by Drugs Classification
  • Interferon Treatment Drugs Import Volume and Market Share
  • Imatinib Mesylate Treatment Drugs Import Volume and Market Share
  • Rituximab Treatment Drugs Import Volume and Market Share
  • Pirarubicin Treatment Drugs Import Volume and Market Share
  • Hydroxycampothecin Treatment Drugs Import Volume and Market Share
  • Other Blood Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel